The two aims of the Immnoassay Core are 1) to perform the antigen specific antibody assays, and 2) to candidate the lymphokines and/or cytokines produced by lymphocytes and antigen presenting cells cultured in presence of antigen. Performing this assay in a core laboratory assures that the antibodies and cytokines are measured in a standardized and uniform manner for the different experiments performed by investigators of three subprojects. Specific functions of the first aim are to routinely quantitate the specific IgG2a, IgG1 and EgE antibodies in all mice that were immunized under different conditions. In addition, assays will be made available to quantitate specific antibodies of the other isotypes and quantitation of total IgE levels, assays that will be needed for special experiments and for control purposes in the study of the nature of pDNA immunization. These measurements will be performed by enzyme linked and radioimmunoassays (ELISA and RIA) that have been established in our laboratories during our previous work on the regulation of IgE antibody formation. The specific function of the second aim of the is core is to determine the interferon-gamma (IFN-gamma) and interleukin 4 (Il-4) production in cell supernatants. In addition assays will be performed for quantitation of other lymphokines and cytokines, especially IL-2, IL-5, and interferon-beta (IFN-beta). In order to avoid dominance or special preference of the core facility for one or the other project, first priority independent of the project will be given to IgE analyses since control of IgE formation is the primary objective of the grant and knowledge of the effect of different experimental conditions on IgE formation is crucial for planning subsequent experiments.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
1P01AI040682-01A1
Application #
6235552
Study Section
Project Start
1997-09-30
Project End
1998-08-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Lee, Jongdae; Abe, Kazumichi; Katakura, Kyoko et al. (2009) The protective effects of type-1 interferon in models of intestinal inflammation. Adv Exp Med Biol 633:1-6
Hayashi, Tomoko; Cottam, Howard B; Chan, Michael et al. (2008) Mast cell-dependent anorexia and hypothermia induced by mucosal activation of Toll-like receptor 7. Am J Physiol Regul Integr Comp Physiol 295:R123-32
Wu, Christina C N; Sabet, Mojgan; Hayashi, Tomoko et al. (2008) In vivo efficacy of a phosphodiester TLR-9 aptamer and its beneficial effect in a pulmonary anthrax infection model. Cell Immunol 251:78-85
Lee, Jongdae; Gonzales-Navajas, Jose M; Raz, Eyal (2008) The ""polarizing-tolerizing"" mechanism of intestinal epithelium: its relevance to colonic homeostasis. Semin Immunopathol 30:3-9
Lane, Nancy E; Nevitt, Michael C; Lui, Li-Yung et al. (2007) Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian women. Arthritis Rheum 56:3319-25
Batzer, Glenda; Lam, Diane P; Paulus, Petra et al. (2007) Using house dust extracts to understand the immunostimulatory activities of living environments. Immunobiology 212:491-8
Hayashi, Tomoko; Mo, Ji-Hun; Gong, Xing et al. (2007) 3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis. Proc Natl Acad Sci U S A 104:18619-24
Abe, Kazumichi; Nguyen, Kim Phung; Fine, Sean D et al. (2007) Conventional dendritic cells regulate the outcome of colonic inflammation independently of T cells. Proc Natl Acad Sci U S A 104:17022-7
Raz, Eyal (2007) Organ-specific regulation of innate immunity. Nat Immunol 8:3-4
Wu, Christina C N; Hayashi, Tomoko; Takabayashi, Kenji et al. (2007) Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand. Proc Natl Acad Sci U S A 104:3990-5

Showing the most recent 10 out of 88 publications